#Astrazeneca sas interview questions full#

Research suggests they have a one in 1,000 chance of developing a blood clot known as a deep vein thrombosis (DVT) within a year.ДЄnd of those who do, about 6 per cent will die. Let's just take a random adult off the street. It must be remembered that other types of blood clots are also very dangerous and can readily move around the body, landing in the brain or lung, where they can be fatal.ДЄnd common medications - and normal life events - are known to increase the risk of clotting. 'In both cases, clotting appears within two weeks of administration of the substances.' Clotting and 'the pill' 'This type of immune reaction involves platelets and white blood cells, and that is the reason for the development of severe clotting. 'This is similar to another relatively rare but serious clotting condition, caused by the use of heparin,' Dr Perdomo said. Read moreДЄccording to UNSW haematology senior researcher Jose Perdomo, it appears 'very likely' that the AstraZeneca vaccine triggers a unique immune reaction characterised by low platelet count and clotting. Got questions about the COVID-19 vaccines being used in Australia? We have answers. So just how serious are the risks of blood clotting from the AstraZeneca vaccine? How safe is it? But it's very likely there will be more hesitation following this latest announcement. Recommendations remain that those over 50 take the AstraZeneca vaccine.

#Astrazeneca sas interview questions full#

Read our full coverage of the coronavirus pandemic Official advice in Australia has been changed, now saying that for Australians under 50, the Pfizer vaccine is the preferred option.Д¬hief medical officer Paul Kelly described the move as a 'very cautious approach'.Д«rendan Murphy - former chief medical officer and now health department boss - said the 'highly precautionary' approach was possible here 'because we're in a fortunate position with COVID'.Д«ut at the same time, authorities have also said the AstraZeneca vaccine could still be used in adults under 50 if 'the benefits are likely to outweigh the risks for that individual and the person has made an informed decision based on an understanding of the risks and benefits'. Australia's COVID-19 vaccine rollout has been bumped severely off track as a result of the likely link to an exceedingly rare side effect that potentially causes deadly blood clots.